+1.62%

S&O 500 5,382.45

-0.47%

US 10 400

+2.28%

Nasdaq 16,565.41

+2.28%

Crude Oil 16,565.41

-0.27%

FTSE 100 8,144.87

+1.06%

Gold 2,458.10

-0.53%

Euro 1.09

+0.36%

Pound/Dollar 1.27

Monday, November 16, 2026

Novo says Wegovy lowers BMI, obesity rates in children in trial

by marketdash
0 comments

Novo on Monday released full results from a late-stage trial showing its blockbuster Wegovy injection helped children ages 6 to under 12 with obesity shed weight, significantly lowering their body mass index.

Wegovy reduced BMI by an estimated 19.7 percentage points on average compared with a placebo at 68 weeks, with BMI falling 17.4% among children receiving the drug and rising 2.2% among those receiving a placebo. Those results assumed patients stayed on treatment during the trial. 

When evaluating all children in the study, including those who discontinued treatment, Wegovy lowered BMI by an estimated average of 16.2 percentage points more than the placebo at 68 weeks. All 167 kids in the study received lifestyle modifications throughout the trial, including a ​reduced-calorie diet and increased physical activity. 

The detailed results mark an encouraging step forward in treating childhood obesity — a chronic disease that can…

Read more…

You may also like

Get New Updates nto Take Care Your Pet

Discover the art of creating a joyful and nurturing environment for your beloved pet.

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Will be used in accordance with our Privacy Policy

@ 2024 – Marketdash – All Rights Reserved.